Does INVESTIGATIONAL BIOSIMILARS Cause Off label use? 31 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Off label use have been filed in association with INVESTIGATIONAL BIOSIMILARS. This represents 19.4% of all adverse event reports for INVESTIGATIONAL BIOSIMILARS.
31
Reports of Off label use with INVESTIGATIONAL BIOSIMILARS
19.4%
of all INVESTIGATIONAL BIOSIMILARS reports
9
Deaths
8
Hospitalizations
How Dangerous Is Off label use From INVESTIGATIONAL BIOSIMILARS?
Of the 31 reports, 9 (29.0%) resulted in death, 8 (25.8%) required hospitalization, and 2 (6.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INVESTIGATIONAL BIOSIMILARS. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does INVESTIGATIONAL BIOSIMILARS Cause?
Underdose (42)
Overdose (30)
Neutrophil count decreased (29)
Anaemia (28)
Neuropathy peripheral (25)
Diarrhoea (23)
Decreased appetite (21)
Platelet count decreased (19)
Nausea (18)
Her2 positive gastric cancer (17)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INVESTIGATIONAL BIOSIMILARS Alternatives Have Lower Off label use Risk?
INVESTIGATIONAL BIOSIMILARS vs INVESTIGATIONAL PRODUCT
INVESTIGATIONAL BIOSIMILARS vs INVOKANA
INVESTIGATIONAL BIOSIMILARS vs IOBENGUANE I-131
INVESTIGATIONAL BIOSIMILARS vs IOBITRIDOL
INVESTIGATIONAL BIOSIMILARS vs IODINE